Literature DB >> 25065884

Assays for necroptosis and activity of RIP kinases.

Alexei Degterev1, Wen Zhou2, Jenny L Maki1, Junying Yuan3.   

Abstract

Necrosis is a primary form of cell death in a variety of human pathologies. The deleterious nature of necrosis, including its propensity to promote inflammation, and the relative lack of the cells displaying necrotic morphology under physiologic settings, such as during development, have contributed to the notion that necrosis represents a form of pathologic stress-induced nonspecific cell lysis. However, this notion has been challenged in recent years by the discovery of a highly regulated form of necrosis, termed regulated necrosis or necroptosis. Necroptosis is now recognized by the work of multiple labs, as an important, drug-targetable contributor to necrotic injury in many pathologies, including ischemia-reperfusion injuries (heart, brain, kidney, liver), brain trauma, eye diseases, and acute inflammatory conditions. In this review, we describe the methods to analyze cellular necroptosis and activity of its key mediator, RIP1 kinase.
© 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Cell death; MLKL; Necroptosis; Necrosis; Necrosome; RIP1; RIP3

Mesh:

Substances:

Year:  2014        PMID: 25065884     DOI: 10.1016/B978-0-12-801430-1.00001-9

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  18 in total

1.  An alternative mitophagy pathway mediated by Rab9 protects the heart against ischemia.

Authors:  Toshiro Saito; Jihoon Nah; Shin-Ichi Oka; Risa Mukai; Yoshiya Monden; Yasuhiro Maejima; Yoshiyuki Ikeda; Sebastiano Sciarretta; Tong Liu; Hong Li; Erdene Baljinnyam; Diego Fraidenraich; Luke Fritzky; Peiyong Zhai; Shizuko Ichinose; Mitsuaki Isobe; Chiao-Po Hsu; Mondira Kundu; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2019-01-22       Impact factor: 14.808

2.  Reply: CYLD variants in frontotemporal dementia associated with severe memory impairment in a Portuguese cohort.

Authors:  Lisa J Oyston; Zac Chatterton; Marianne Hallupp; Neil Rajan; John B Kwok; Carol Dobson-Stone
Journal:  Brain       Date:  2020-08-01       Impact factor: 13.501

Review 3.  Programmed cell death in aging.

Authors:  John Tower
Journal:  Ageing Res Rev       Date:  2015-04-08       Impact factor: 10.895

4.  Aluminum-induced "mixed" cell death in mice cerebral tissue and potential intervention.

Authors:  Yan-Xia Hao; Mei-Qin Li; Jing-Si Zhang; Qin-Li Zhang; Xia Jiao; Xiu-Liang Ji; Huan Li; Qiao Niu
Journal:  Neurotox Res       Date:  2019-11-13       Impact factor: 3.911

5.  Inhibition of TWEAK/Tnfrsf12a axis protects against acute liver failure by suppressing RIPK1-dependent apoptosis.

Authors:  Zhijie Li; Heming Wang; Junjin Zhu; Ning Nan; Yi Lin; Xuran Zhuang; Ling Li; Yamin Zhang; Pengyu Huang
Journal:  Cell Death Discov       Date:  2022-07-19

6.  Cholesterol Sulfonation Enzyme, SULT2B1b, Modulates AR and Cell Growth Properties in Prostate Cancer.

Authors:  Renee E Vickman; Scott A Crist; Kevin Kerian; Livia Eberlin; R Graham Cooks; Grant N Burcham; Kimberly K Buhman; Chang-Deng Hu; Andrew D Mesecar; Liang Cheng; Timothy L Ratliff
Journal:  Mol Cancer Res       Date:  2016-06-24       Impact factor: 5.852

Review 7.  The Receptor Interacting Protein Kinases in the Liver.

Authors:  Lily Dara
Journal:  Semin Liver Dis       Date:  2018-02-22       Impact factor: 6.115

Review 8.  Questions and controversies: the role of necroptosis in liver disease.

Authors:  Lily Dara; Zhang-Xu Liu; Neil Kaplowitz
Journal:  Cell Death Discov       Date:  2016-12-05

9.  TNF-α sensitizes chemotherapy and radiotherapy against breast cancer cells.

Authors:  Xiao Wu; Meng-Yao Wu; Min Jiang; Qiaoming Zhi; Xiaojie Bian; Meng-Dan Xu; Fei-Ran Gong; Juan Hou; Min Tao; Liu-Mei Shou; Weiming Duan; Kai Chen; Meng Shen; Wei Li
Journal:  Cancer Cell Int       Date:  2017-01-23       Impact factor: 5.722

Review 10.  Cell apoptosis, autophagy and necroptosis in osteosarcoma treatment.

Authors:  Jing Li; Zuozhang Yang; Yi Li; Junfeng Xia; Dongqi Li; Huiling Li; Mingyan Ren; Yedan Liao; Shunling Yu; Yanjin Chen; Yihao Yang; Ya Zhang
Journal:  Oncotarget       Date:  2016-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.